Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

KIAA1524 anticorps (AA 853-903)

L’anticorps Lapin Polyclonal anti-KIAA1524 a été validé pour WB, IP et IHC (fp). Il convient pour détecter KIAA1524 dans des échantillons de Humain, Souris et Rat.
N° du produit ABIN7453880

Aperçu rapide pour KIAA1524 anticorps (AA 853-903) (ABIN7453880)

Antigène

Voir toutes KIAA1524 Anticorps
KIAA1524

Reactivité

  • 42
  • 21
  • 15
  • 1
Humain, Souris, Rat

Hôte

  • 36
  • 9
Lapin

Clonalité

  • 36
  • 9
Polyclonal

Conjugué

  • 25
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp KIAA1524 est non-conjugé

Application

  • 35
  • 8
  • 8
  • 7
  • 6
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))
  • Épitope

    • 12
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 853-903

    Fonction

    Rabbit anti-CIP2A Antibody, Affinity Purified

    Purification

    Affinity Purified

    Immunogène

    between AA 853 and 903

    Isotype

    IgG
  • Indications d'application

    IHC: 1:100 to 1:500. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.

    IP: 2 - 10 μg/mg lysate

    WB: 1:2,000 - 1:10,000

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Date de péremption

    12 months
  • Antigène

    KIAA1524

    Autre désignation

    CIP2A

    Sujet

    Background: CIP2A (cancerous inhibitor of PP2A) was originally identified as p90, a cytoplasmic autoantigen found in the serum from a cancer patient. It was later described as a protein that interacted with the c-myc oncogene and functioned as an inhibitor of protein phosphatase 2A (PP2A) activity. Inhibition of PP2A phosphatase activity by CIP2A prevents c-myc phosphorylation and counteracts c-myc proteolytic degradation, thereby stabilizing c-myc and promoting cell growth and transformation. CIP2A is found to be overexpressed in some human malignancies and is thus classified as an oncogene that may be an important contributor to tumor formation.

    ID gène

    57650

    NCBI Accession

    NP_065941

    UniProt

    Q8TCG1
Vous êtes ici:
Chat with us!